Združene države Amerike - angleščina - NLM (National Library of Medicine)

west-ward pharmaceutical corp - butalbital (unii: khs0az4jvk) (butalbital - unii:khs0az4jvk), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - butalbital 50 mg - butalbital, acetaminophen, and caffeine capsules, usp are indicated for the relief of the symptom complex of tension (or muscle contraction) headache. evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable. caution in this regard is required because butalbital is habit-forming and potentially abusable. this product is contraindicated under the following conditions: * hypersensitivity or intolerance to any component of this product. * patients with porphyria. butalbital :  barbiturates may be habit - forming:   tolerance, psychological dependence, and physical dependence may occur especially following  prolonged use of high doses of barbiturates. the average daily dose for the barbiturate  addict is usually about 1500 mg. as tolerance to barbiturates develops, the amount needed to  maintain the same level of intoxication increases; tolerance to a fatal dosage, however, does not  increase more than two-fold. as this occurs, the ma

Združene države Amerike - angleščina - NLM (National Library of Medicine)

west-ward pharmaceutical corp - isosorbide mononitrate (unii: lx1oh63030) (isosorbide - unii:wxr179l51s) - isosorbide mononitrate 20 mg - isosorbide mononitrate is indicated for the prevention and treatment of angina pectoris due to coronary artery disease. the onset of action of oral isosorbide mononitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode. allergic reactions to organic nitrates are extremely rare, but they do occur. isosorbide mononitrate is contraindicated in patients who are allergic to it.

Združene države Amerike - angleščina - NLM (National Library of Medicine)

west-ward pharmaceutical corp - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u) - ciprofloxacin 500 mg - ciprofloxacin tablets, usp are indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions and patient populations listed below. please see dosage and administration   for specific recommendations. adult patients urinary tract infections caused by escherichia coli , klebsiella pneumoniae , enterobacter cloacae , serratia marcescens , proteus mirabilis , providencia rettgeri , morganella morganii , citrobacter diversus , citrobacter freundii , pseudomonas aeruginosa , methicillin-susceptible staphylococcus epidermidis , staphylococcus saprophyticus , or enterococcus faecalis . acute uncomplicated cystitis in females caused by escherichia coli or staphylococcus saprophyticus. chronic bacterial prostatitis caused by escherichia coli or proteus mirabilis. lower respiratory tract infections caused by escherichia coli, klebsiella pneumoniae, enterobacter cloacae, proteus mirabilis, pseudomonas aeruginosa, haemophilus influenzae, haemophilus parain

Združene države Amerike - angleščina - NLM (National Library of Medicine)

west-ward pharmaceutical corp - fludrocortisone acetate (unii: v47if0pvh4) (fludrocortisone - unii:u0476m545b) - fludrocortisone acetate 0.1 mg - fludrocortisone acetate tablets, 0.1 mg are indicated as partial replacement therapy for primary and secondary adrenocortical insufficiency in addison’s disease and for the treatment of salt-losing adrenogenital syndrome. corticosteroids are contraindicated in patients with systemic fungal infections and in those with a history of possible or known hypersensitivity to these agents.

Združene države Amerike - angleščina - NLM (National Library of Medicine)

west-ward pharmaceutical corp - lithium carbonate (unii: 2bmd2gna4v) (lithium cation - unii:8h8z5uer66) - lithium carbonate 450 mg - lithium carbonate is indicated in the treatment of manic episodes of manic-depressive illness. maintenance therapy prevents or diminishes the intensity of subsequent episodes in those manic-depressive patients with a history of mania. typical symptoms of mania include pressure of speech, motor hyperactivity, reduced need for sleep, flight of ideas, grandiosity, elation, poor judgment, aggressiveness and possibly hostility. when given to a patient experiencing a manic episode, lithium carbonatemay produce a normalization of symptomatology within 1 to 3 weeks.

Združene države Amerike - angleščina - NLM (National Library of Medicine)

west-ward pharmaceutical corp - lithium carbonate (unii: 2bmd2gna4v) (lithium cation - unii:8h8z5uer66) - lithium carbonate 300 mg - lithium carbonate tablets, usp are indicated in the treatment of manic episodes of bipolar disorder. bipolar disorder, manic (dsm-iii) is equivalent to manic depressive illness, manic, in the older dsm-ii terminology. lithium carbonate tablets, usp are also indicated as a maintenance treatment for individuals with a diagnosis of bipolar disorder. maintenance therapy reduces the frequency of manic episodes and diminishes the intensity of those episodes which may occur. typical symptoms of mania include pressure of speech, motor hyperactivity, reduced need for sleep, flight of ideas, grandiosity, elation, poor judgment, aggressiveness, and possibly hostility. when given to a patient experiencing a manic episode, lithium may produce a normalization of symptomatology within 1 to 3 weeks. lithium should generally not be given to patients with significant renal or cardiovascular disease, severe debilitation or dehydration, or sodium depletion, and to patients receiving diuretics, since the risk of lithium toxicity

Združene države Amerike - angleščina - NLM (National Library of Medicine)

west-ward pharmaceutical corp. - glycopyrrolate (unii: v92so9wp2i) (glycopyrrolate - unii:v92so9wp2i) - glycopyrrolate 0.2 mg in 1 ml - glycopyrrolate injection is indicated for use as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions; to reduce the volume and free acidity of gastric secretions; and to block cardiac vagal inhibitory reflexes during induction of anesthesia and intubation. when indicated, glycopyrrolate injection may be used intraoperatively to counteract surgically or drug-induced or vagal reflexes associated arrhythmias. glycopyrrolate protects against the peripheral muscarinic effects (e.g., bradycardia and excessive secretions) of cholinergic agents such as neostigmine and pyridostigmine given to reverse the neuromuscular blockade due to non-depolarizing muscle relaxants. for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or when oral medication is not tolerated. known hypersensitivity to glycopyrrolate or any of its inactive ingredients. in addition, in the management of peptic ulcer patients, because of the lo

Združene države Amerike - angleščina - NLM (National Library of Medicine)

west-ward pharmaceutical corp - isosorbide dinitrate (unii: ia7306519n) (isosorbide dinitrate - unii:ia7306519n) - isosorbide dinitrate 2.5 mg - isosorbide dinitrate sublingual tablets are indicated for the prevention and treatment of angina pectoris due to coronary artery disease. however, because the onset of action of sublingual isdn is significantly slower than that of sublingual nitroglycerin, sublingual isdn is not the drug of first choice for abortion of an acute anginal episode. allergic reactions to organic nitrates are extremely rare, but they do occur. the isosorbide dinitrate sublingual tablet is contraindicated in patients who are allergic to isdn or any of its other ingredients.

Združene države Amerike - angleščina - NLM (National Library of Medicine)

west-ward pharmaceutical corp. - isosorbide dinitrate (unii: ia7306519n) (isosorbide dinitrate - unii:ia7306519n) - tablet - 30 mg - isosorbide dinitrate tablets are indicated for the prevention of angina pectoris due to coronary artery disease. the onset of action of immediate-release oral isosorbide dinitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode. allergic reactions to organic nitrates are extremely rare, but they do occur. the isosorbide dinitrate tablet is contraindicated in patients who are allergic to isdn or any of its other ingredients.

Združene države Amerike - angleščina - NLM (National Library of Medicine)

west-ward pharmaceutical corp - isosorbide dinitrate (unii: ia7306519n) (isosorbide dinitrate - unii:ia7306519n) - isosorbide dinitrate 30 mg - isosorbide dinitrate tablets, usp, are indicated for the prevention of angina pectoris due to coronary artery disease. the onset of action of immediate-release oral isosorbide dinitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode. allergic reactions to organic nitrates are extremely rare, but they do occur. the isosorbide dinitrate tablet is contraindicated in patients who are allergic to isdn or any of its other ingredients